Arctoris To Overhaul Drug Discovery With Automation

 
• By Kevin Grogan

Building a robotics infrastructure "is the only way to make sure we generate data of sufficient quality at the speed and scale required, and now everybody in the pharma industry is very excited about the idea of end-to-end automation." So says Martin-Immanuel Bittner, CEO of Arctoris.

innovation concept
• Source: Alamy

Back To Rising Leaders Gallery

Martin-Immanuel Bittner is a medical doctor and cancer researcher turned life sciences entrepreneur who as co-founder and CEO of Arctoris,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from C-Suite Speaks

More from Leadership